Share Name Share Symbol Market Type Share ISIN Share Description
GlaxoSmithKline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +16.40p +1.25% 1,325.00p 1,326.80p 1,327.20p 1,332.00p 1,311.00p 1,312.00p 7,581,893 16:35:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 30,186.0 3,525.0 31.4 42.2 65,696.08

GlaxoSmithKline Share Discussion Threads

Showing 16776 to 16799 of 16800 messages
Chat Pages: 672  671  670  669  668  667  666  665  664  663  662  661  Older
DateSubjectAuthorDiscuss
20/2/2018
23:09
Continued to drop in the US after the UK close too.
tim 3
20/2/2018
20:53
3 Execs, dumped some £450K of stock today .......to meet tax liabilities.
bili1946
20/2/2018
14:01
Everyone as different investment strategies, but why with a share yielding 6.04% ex div this Thursday 23p. Shares fallen from 1625p to 1305p just on something they may do, bid for Pfizer consumer division, ok investors worried about dividend if they did win. Its probability 90% won't win, 10% will win is my view, when I think odds in my favour I invest. If wrong ok getting paid 6% while I wait for them to recover.
montyhedge
20/2/2018
12:44
I get it,but thanks for the thought!
abdullla
20/2/2018
12:35
"Tick" option has disappeared from my screen.
gbh2
20/2/2018
12:12
No one of course knows, its all probability, but if GSK lose Pfizer consumer bid, my thoughts are 90% wont win, 10% they might win. We fell from 1625p to 1305p on the idea we may bid, which was overdone. So in theory we should at least go back over 1420p.The figures were superb recently, this is just holding us back. If we did win, Emma said she would not pay over the odds for that division. I hope she is bluffing on this deal and making RB pay up, lol.
montyhedge
20/2/2018
11:13
I don't think on Thursday will we drop the 23p ex dividend, I reckon 15p so really 10p rise. All looking good for GSK.
montyhedge
20/2/2018
10:59
Sorry I forgot to mention Marconi.
abdullla
20/2/2018
10:55
I give one ? tick to every one who posts here ,Once upon a time i used to do the same for Baltimore & Energis posters ,some I see here,here's to old times sake !
abdullla
20/2/2018
08:52
I'm 90% certain we won't bid, or if we do be a low amount. RB need it more than us. Look how we fell from 1625p to 1305p just on GSK thinking about it, lol.
montyhedge
20/2/2018
08:39
romeike - My sentiments entirely, why aren't the private equity boys interested?
ianood
20/2/2018
08:26
Ermm, wrong currency. It has an estimated price tag of $15bn (£10.7bn) to $20bn.
tradermichael
20/2/2018
08:19
Yes £20 billion no chance, RB need it more than GSK.We fallen from 1625p to 1305p just on the thought of GSK being interested. Should have a nice bounce if we lose.
montyhedge
19/2/2018
22:34
I suspect neither will end up buying it. I recall a Pfizer spokesman said (after GSK and RB were given closed-door access) that Pfizer was keeping all its options open, including no sale. Made me think they were laying the ground for no deal. The figures they came out with, $20bn etc were also quite pie in the sky.
romeike
19/2/2018
19:24
https://www.google.co.uk/amp/s/www.bloomberg.com/amp/gadfly/articles/2018-02-07/pfizer-s-20-billion-pill-is-too-bitter-for-glaxo
montyhedge
19/2/2018
19:21
I filtered him some time ago.
montyhedge
19/2/2018
17:29
abdullla19 Feb '18 - 14:42 - 16717 of 16719 (Filtered) abdullla19 Feb '18 - 16:26 - 16719 of 16719 (Filtered) I don't know why he bothers posting tbh
romeike
19/2/2018
16:26
When will the bidding process begin and end?
abdullla
19/2/2018
15:21
Well GSK had great results, if we did win, no downside in shareprice. GSK have fallen from 1625p to 1305p on the thought of GSK making a bid. LolEither way I think shareprice will rise.
montyhedge
19/2/2018
14:42
May I predict GSK will succeed in buying but pay high for it in cash & paper,let us see !
abdullla
19/2/2018
14:27
OR to put it another way - I would be amazed if RB. did make another acquisition after the last one was so badly received......
toffeeman
19/2/2018
14:07
Well after today's disappointing results from RB, I will be amazed if they don't out bid GSK let's hope so.Emma did say she would not overpay.RB will.
montyhedge
19/2/2018
14:03
Pfizer, largely a prescription drug company, like GSK, obviously looking to offload consumer health to concentrate on core business (these things are cyclical). I would have thought that the same applies to GSK. RB is not a threat to GSK's core market, so let them have the PCH and pay over the odds for it .....
tradermichael
19/2/2018
12:28
I had not realised how far down the Big Pharma global table GSK had fallen; nor how big the Swiss Novartis and Roche have become. Not long ago it was Pfizer 1 and GSK 2. Not any more.
alphorn
Chat Pages: 672  671  670  669  668  667  666  665  664  663  662  661  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180220 23:48:14